The effect of buprenorphine and benzodiazepines on respiration in the rat

Drug and Alcohol Dependence

Volumn 79, Issue 1, 2005, Pages 95-101

  Nielsen, Suzanne ^a,b   Taylor, David A ^a  

^a MONASH UNIVERSITY   (Australia)

^b Turning Point Alcohol Drug Ctr Inc   (Australia)

Author keywords

Benzodiazepines; Buprenorphine; Respiratory depression

Indexed keywords

BUPRENORPHINE; DIAZEPAM; METHADONE;

ANIMAL EXPERIMENT; ARTICLE; BREATHING; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATION DEPRESSION;

EID: 27644545796     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2005.01.004     Document Type: Article

References (50)

1. Al-Khudhairi, D., Whitwam, J.G., Askitopoulou H, 1982. Acute central respiratory effects of diazepam, its solvent and propylene glycol. Br. J. Anaesth. 54, 959-964.
2. Auriacombe, M., Franques, P., Tignol, J., 2001. Deaths attributable to methadone v s buprenorphine in France. JAMA 285, 45.
3. Barnett, P.G., Rodgers, J.H., Bloch, D.A., 2001. A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence. Addiction 96, 683-690.
4. Borron, S.W., Monier, C., Risede, P., Baud, F.J., 2002. Flunitrazepam variably alters morphine, buprenorphine, and methadone lethality in the rat. Hum. Exp. Toxicol. 21, 599-605.
5. Caplehorn, J.R., Drummer, O.H., 1999. Mortality associated with New South Wales methadone programs in 1994: lives lost and saved. Med. J. Aust. 170, 104-109.
6. Caplehorn, J.R.M., Drummer, O.H., 2002. Fatal methadone toxicity: signs and circumstances, and the role of benzodiazepines. Aust. N. Z. J. Public Health 26, 358-362 (discussion 362 and 363).
7. Cowan, A., Doxey, J.C., Harry, E.J., 1977. The animal pharmacology of buprenorphine, an oripavine analgesic agent. Br. J. Pharmacol. 60, 547-554.
8. Darke, S., Ross, J., Teesson, M., Lynskey, M., 2003. Health service utilization and benzodiazepine use among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Addiction 98, 1129-1135.
9. Ernst, E., Bartu, A., Popescu, A., Ileutt, K.F., Hansson, R., Plumley N, 2002. Methadone-related deaths in Western Australia 1993-99. Aust. N. Z. J. Public Health 26, 364-370.
10. Faroqui, M.H., Cole, M., Curran, J., 1983. Buprenorphine, benzodiazepines and respiratory depression. Anaesthesia 38, 1002-1003.
11. Fiellin, D., Lintzeris, N., 2003. Methadone syrup injection in Australia: a sentinel finding? Addiction 98, 385-386.
12. Forrest, A.L., 1983. Buprenorphine and lorazepam. Anaesthesia 38, 598.
13. Fox, S.I., 1996. Human Physiology. Wm. C. Brown, Dubuque, U.S.A.
14. Gaulier, J.M., Marquet, P., Lacassie, E., Dupuy, J.L., Lachatre, G., 2000. Fatal intoxication following self-administration of a massive dose of buprenorphine. J. Forensic Sci. 45, 226-228.
15. Gueye, RN., Borron, S.W., Risede, P., Monier, C., Buneaux, F., Debray, M., Baud, F.J., 2001. Lack of effect of single high doses of buprenorphine on arterial blood gases in the rat. Toxicol. Sci. 62, 148-154.
16. Gueye, RN., Borron, S.W., Risede, P., Monier, C., Buneaux, F., Debray, M., Baud FJ, 2002a. Buprenorphine and midazolam act in combination to depress respiration in rats. Toxicol. Sci. 65, 107-114.
17. Gueye, P.N., Lofaso, F., Borron, S.W., Mellerio, F., Vicaut, E., Harf, A., Baud, F.J., 2002b. Mechanism of respiratory insufficiency in pure or mixed drug-induced coma involving benzodiazepines. J. Toxicol. Clin. Toxicol. 40, 35-47.
18. Jain, P.N., Shah, S.C., 1993. Respiratory depression following combination of epidural buprenorphine and intramuscular ketorolac. Anaesthesia 48, 898-899.
19. Jenkinson, R., Fry, C., Miller, P., 2002. Victorian Drug Trends 2002: Findings of the Illicit Drug Reporting System (IDRS). Technical Report No. 145, Australia.
20. Jenkinson, R., Clark, N.C., Fry, C.L., Dobbin, M., 2004. Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue? Addiction (Online).
21. Johnson, R.E., Jaffe, J.H., Fudala, P.J., 1992. A controlled trial of buprenorphine treatment for opioid dependence. JAMA 267, 2750-2755.
22. Kintz, P., 2001. Deaths involving buprenorphine: a compendium of French cases. Forensic Sci. Int. 121, 65-69.
23. Kintz, P., 2002. A new series of 13 buprenorphine-related deaths. Clin. Biochem. 35, 513-516.
24. Korkmaz, S., Wahlstrom, G., 1999. Physical dependence after benzodiazepine treatments in rats: comparison of short and long treatments with diazepam and lorazepam. J. Stud. Alcohol 60, 546-554.
25. Kosten, T.R., Schottenfeld, R., Ziedonis, D., Falcioni J, 1993. Buprenorphine versus methadone maintenance for opioid dependence. J. Nerv. Ment. Dis. 181, 358-364.
26. Ling, W., Charuvastra, C., Collins, J.F., Batki, S., Brown Jr., L.S., Kintaudi, P., Wesson, D.R., McNicholas, L., Tusel, D.J., Malkerneker, U., Renner Jr., J.A., Santos, E., Casadonte, P., Fye, C., Stine, S., Wang, R.I., Segal, D., 1998. Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction 93, 475-486.
27. Ling, W., Wesson, D.R., Charuvastra, C., Klett, C.J., 1996. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch. Gen. Psychiatry 53, 401-407.
28. Lintzeris, N., Clark, N., Ritter, A., Muhleisen, P., Ali, R., Bell, J., Cowing, L., Hawkin, L., Henry Edwards, S., Mattick, R.P., Monheit, B., Newton, I., Quigley, A., Whicker, S., White, J., 2001. Clinical Guidelines: buprenorphine treatment of heroin dependence, in 1-74, DHS, Melbourne.
29. McCormick, G.Y., White, W.J., Zagon, I.S., Lang, C.M., 1984. Effects of diazepam on arterial blood gas concentrations and pH of adult rats acutely and chronically exposed to methadone. J. Pharmacol. Exp. Ther. 230, 353-359.
30. Obadia, Y., Perrin, V., Feroni, I., Vlahov, D., Moatti, J.P., 2001. Injecting misuse of buprenorphine among French drug users. Addiction 96, 267-272.
31. Papworth, D.P., 1983. High dose buprenorphine for postoperative analgesia. Anaesthesia 38, 163.
32. Pirnay, S., Borron, S.W., Giudicelli, C.P., Tourneau, J., Baud, F.J., Ricordel, I., 2004. A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. Addiction 99, 978-988.
33. Reynaud, M., Petit, G., Potard, D., Courty, P., 1998. Six deaths linked to concomitant use of buprenorphine and benzodiazepines. Addiction 93, 1385-1392.
34. Schottenfeld, R.S., Pakes, J.R., Oliveto, A., Ziedonis, D., Kosten, T.R., 1997. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch. Gen. Psychiatry 54, 713-720.
35. Sekar, M., Mimpriss, T.J., 1987. Buprenorphine, benzodiazepines and prolonged respiratory depression. Anaesthesia 42, 567-568.
36. Singh, P.P., Junnarkar, A.Y., Seshagirirao, C., Kaushal, R., Naidu, M.U., Varma, R.K., Tripathi, R.M., Shridhar, D.R., 1982. A pharmacological study of propane-1,2-diol. Arzneimittel-Forschung 32, 1443-1446.
37. Strain, E.C., Stitzer, M.L., Liebson, I.A., Bigelow, G.E., 1994. Comparison of buprenorphine and methadone in the treatment of opioid dependence. Am. J. Psychiatry 151, 1025-1030.
38. Study, R.E., Barker, J.L., 1982. Cellular mechanisms of benzodiazepine action. JAMA 247, 2147-2151.
39. Thirion, X., Lapierre, V., Micallef, J., Ronfle, E., Masut, A., Pradel, V., Coudert, C., Mabriez, J.C., Sanmarco, J.L., 2002. Buprenorphine prescription by general practitioners in a French region. Drug Alcohol Depend. 65, 197-204.
40. Thirion, X., Micallef, J., Barrau, K., Djezzar, S., Sanmarco, J.L., Lagier, G., 2001. Observation of psychoactive substance consumption: methods and results of the French OPPIDUM programme. Eur. Addict. Res. 7, 32-36.
41. Thorn, S.E., Rawal, N., Wennhager, M., 1988. Prolonged respiratory depression caused by sublingual buprenorphine. Lancet 1, 179-180.
42. Tracqui, A., Kintz, P., Ludes, B., 1998a. Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities. J. Anal. Toxicol. 22, 430-434.
43. Tracqui, A., Kintz, R, Ludes, B., 1998b. Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities. J. Anal. Toxicol. 22, 430-434.
44. Vignau, J., Duhamel, A., Catteau, J., Legal, G., Pho, A.H., Grailles, I., Beauvillain, J., Petit, P., Beauvillain, P., Parquet, P.J., 2001. Practice-based buprenorphine maintenance treatment (BMT): how do French healthcare providers manage the opiate-addicted patients? J. Subst. Abuse Treat. 21, 135-144.
45. Vormfelde, S.V., Poser, W., 2001. Death attributed to methadone. Pharmacopsychiatry 34, 217-222.
46. Walsh, S.L., Preston, K.L., Stitzer, M.L., Cone, E.J., Bigelow, G.E., 1994. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin. Pharmacol. Ther. 55, 569-580.
47. Wamsley, J.K., 1983. Opioid receptors: autoradiography. Pharmacol. Rev. 35, 69-83.
48. West, S.L., O'Neal, K.K., Graham, C.W., 2000. A meta-analysis comparing the effectiveness of buprenorphine and methadone. J. Subst. Abuse 12, 405-414.
49. White, J.M., Irvine, R.J., 1999. Mechanisms of fatal opioid overdose. Addiction 94, 961-972.
50. White, W.J., Zagon, I.S., 1979. Acute and chronic methadone exposure in adult rats: studies on arterial blood gas concentrations and pH. J. Pharmacol. Exp. Ther. 209, 451-455.